SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome

被引:11
作者
Sun, Shanshan [1 ]
Wang, Miao [1 ,2 ]
Song, Haiyan [1 ]
Wu, Tao [1 ,3 ]
Wei, Huafeng [1 ,2 ]
He, Songhua [2 ]
Ding, Zhaoguo [4 ]
Ji, Guang [1 ,5 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai 200032, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Internal Med Tradit Chinese Med, Shanghai 200032, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Ctr Chinese Med Therapy & Syst Biol, Shanghai 201203, Peoples R China
[4] Uppsala Univ, Dept Stat, SE-75105 Uppsala, Sweden
[5] Shanghai Univ Tradit Chinese Med, E Inst Shanghai Municipal Educ Commiss, Shanghai 201203, Peoples R China
关键词
genetic polymorphism; nonalcoholic fatty liver disease; metabolic syndrome; SCAP; SREBF-1; SREBF-2; CHOLESTEROL; SUSCEPTIBILITY; PREVALENCE; OBESITY;
D O I
10.1007/s12041-013-0280-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:565 / 570
页数:6
相关论文
共 25 条
  • [1] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [2] Metabolic syndrome and non-alcoholic fatty liver disease
    Almeda-Valdes, Paloma
    Cuevas-Ramos, Daniel
    Aguilar-Salinas, Carlos Alberto
    [J]. ANNALS OF HEPATOLOGY, 2009, 8 : S18 - S24
  • [3] Fatty infiltration of liver in hyperlipidemic patients
    Assy, N
    Kaita, K
    Mymin, D
    Levy, C
    Rosser, B
    Minuk, G
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) : 1929 - 1934
  • [4] Pathology of nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (04) : 195 - 203
  • [5] High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Buetow, KH
    Edmonson, M
    MacDonald, R
    Clifford, R
    Yip, P
    Kelley, J
    Little, DP
    Strausberg, R
    Koester, H
    Cantor, CR
    Braun, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) : 581 - 584
  • [6] Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
    Carlson, CS
    Eberle, MA
    Rieder, MJ
    Yi, Q
    Kruglyak, L
    Nickerson, DA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (01) : 106 - 120
  • [7] Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
    Chatrath, Hemant
    Vuppalanchi, Raj
    Chalasani, Naga
    [J]. SEMINARS IN LIVER DISEASE, 2012, 32 (01) : 22 - 29
  • [8] Relationship between nonalcoholic fatty liver disease and metabolic syndrome
    Chen, Shao Hua
    He, Fan
    Zhou, Hua Li
    Wu, Hong Ru
    Xia, Chen
    Li, You Ming
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2011, 12 (02) : 125 - 130
  • [9] Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men
    Fan, YM
    Laaksonen, R
    Janatuinen, T
    Vesalainen, R
    Nuutila, P
    Knuuti, J
    Lehtimäki, T
    [J]. CLINICAL GENETICS, 2001, 60 (04) : 319 - 321
  • [10] Determinants of variable response to simvastatin treatment:: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes
    Fiegenbaum, M
    Silveira, FR
    Van der Sand, CR
    Van der Sand, LC
    Ferreira, MEW
    Pires, RC
    Hutz, MH
    [J]. PHARMACOGENOMICS JOURNAL, 2005, 5 (06) : 359 - 364